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Nanoparticles of carvedilol are prepared by ultrasonic method. Particle sizes and morphology of nanoparticles are
dependent on the power of ultrasound irradiation and sonication time. Results show an increase in the particle size
with increasing the power of ultrasound irradiation. The particle size increased with increasing sonication time. The
produced carvedilol nanoparticles were characterized by X-ray diffraction, infrared spectroscopy, and scanning
electron microscopy.
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One of the major causes of new drug molecules failing
to reach the market is poor bioavailability. Indeed, many
of the newly discovered drug candidates suffer from low
to extremely low water solubility and hence are prone to
limited bioavailability [1-3]. To cope with these issues,
drug formulation scientists are developing formulation
strategies that enhance the dissolution and thus the bio-
availability of these poorly water-soluble drugs [4]. The
most important technologies are applied in the formula-
tion development to enhance solubility and dissolution
which include particle size reduction, salt formation, and
amorphous systems, as well as co-solvents, complexants,
surfactants, and lipid formulations. Among these tech-
niques, particle size reduction is highly promising. Mic-
ronization of drug crystals by various mechanisms to the
lower micron range improves drug dissolution [5].
According to the Noyes-Whitney equation, the dissol-
ution rate increases by increasing the specific surface
area. The saturation solubility increases with decreasing
particle size according to the Ostwald-Freundlich equa-
tion [6,7]. Therefore, reducing particle size to the nano-
range has been investigated through several approaches.
Current methods to prepare drug nanocrystals can be
divided into top-down and bottom-up methods [8,9]. At
present, most industrially feasible methods are the top-
down technologies; all the products on the market are* Correspondence: ha.nabipour@gmail.com
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reproduction in any medium, provided the origmade by size reduction. The major two processes are
ball milling and high-pressure homogenization, either in
water or in non-aqueous water-reduced media. Disad-
vantages of the ball milling process are the relatively
long milling times in the case of hard drug material, the
limited scaling up ability (the weight of the ball mill and
the milling material limit maximum size), and potential
contamination of the milling material by erosion from
the milling pearls [10]. Nanocrystal production by high-
pressure homogenization requires typically 10 to 20 ho-
mogenization cycles at pressures of, e. g., 1,000 to 1,500
bar. Metal contamination from the homogenizer is obvi-
ously not a problem. However, despite when using a
high-capacity homogenizer with 1 ton product per hour,
the acceleration of production by reduction of the
homogenization cycle number would be desirable. Cur-
rently, the utilization of ultrasound for material synthesis
has been extensively examined over many years, and it is
now positioned as one of the most powerful tools in
nanostructured material synthesis. Acoustic cavitation
provides a unique interaction of energy and matter, and
ultrasonic irradiation of liquids causes high-energy
chemical reactions to occur, often accompanied by the
emission of light [11]. Bubbles generated during sonic-
ation can effectively accumulate the diffuse energy of
ultrasound, and upon collapse, an enormous concentra-
tion of energy is released to heat the contents of the
bubble. These transient, localized hot spots with ex-
tremely high temperatures and pressures are primarily
responsible for the chemical effects of ultrasound [12].his is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
Figure 1 SEM images of carvedilol nanoparticles in (A) sample
1 and (B) sample 2.
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tool resides in its versatility. With a simple modification in
the reaction conditions, various forms of nanostructured
materials can be synthesized, including metals [13,14], car-
bides [15] and sulfides [16] which are nanostructured sup-
ported catalysts.
Carvedilol, (+)–1-(Carbazol-4-yloxy)-3-f[2-(o-methoxyphe
noxy)ethyl]aminog-2-propanol, is a β-receptor blocker and
antihypertensive drug with a multiple-action spectrum [17],
and it also has vasodilating properties that are attributed
mainly to its blocking activity at α1 receptors. The use of
carvedilol has been shown to provide additional morbidity
and mortality benefits in severe congestive heart failure
[18]. Previously, Varshosaz et al. reported the preparation of
carvedilol nanoparticles by emulsification method [19].
Kalimuthu et al. reported the formulation of carvedilol-
loaded Eudragit e 100 nanoparticles [20]. In this paper, we
have developed a simple ultrasonic method to prepare
nanocarvedilol and studied some parameters, such as sonic-
ation time and ultrasonic device power in the size and
morphology of the carvedilol nanoparticles. The result
shows that different particle diameters of carvedilol were
prepared, and infrared studies show that the bonds do not
change.Results and discussion
Various conditions for the preparation of carvedilol nano-
particles were summarized in Table 1. In series 1, the reac-
tions were studied in 20 and 40 min. Results show that
the particle size in sample 1 (Figure 1B) is smaller than
that of 2 (Figure 1A). This point shows that an increase in
the sonication time led to an increase in the particle size.
In the same way, an increase in the sonication time led to
the increase of the particle sizes in sample 4 (Figure 2B).
Various ultrasound powers led to different morphologies.
Samples 1 and 2 have amorphous structures, but the mor-
phology of samples 3 and 4 changed to spherical struc-
tures, and their particle distribution is uniform. Particle
size in sample 3 is smaller than that of 4. Therefore, the
best morphology with smaller particles and good distri-
bution was obtained from sample 4 with the sonication
time of 40 min and the ultrasound device power of 80 W








Series 1 1 20 60 21
2 40 60 48
Series 2 3 20 80 64
4 40 80 96
Figure 2 SEM images of carvedilol nanoparticles in (A) sample
3 and (B) sample 4.
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(FTIR) spectrum pattern of the nanocarvedilol in the range
of 400 to 4,000 cm−1. The IR spectrum of pure carvedilol
showed the peak at 3,344.88 cm–1 (N-H, str), which corre-
sponds to N-H stretching. The hetero-aromatic structure
shows the presence of the C-H stretching vibrations in the
region 2995.87 cm–1 (C-H, Sp2), also in 2923.56 cm–1,
which is the characteristic region for the ready identifica-
tion of the C-H stretching vibrations. The bands corre-
sponding to the in-plane C-H deformations are observed
in the regions 1,000 to 1,300 cm−1. The bands are sharp
but of weak to minimum intensity. The medium- and
strong-intensity bands are in the regions 1,099.72,
1,119.95, 1,156.24, and 1,177.15 cm−1 in the FT-IR
spectrum. A medium experimental peak around 1252
to 1,402 cm−1 in the FT-IR was assigned to the C-C
stretching vibrations. The bands in the regions 1,502 to
1,607 cm−1 observed in both FT-IR were assigned to theFigure 3 Room-temperature FT-IR spectra of carvedilol and nanocarvC=C stretching vibrations. In the present case, the bands
observed at 849.50 and 783.90 cm−1 in the FT-IR are
assigned to the ring breathing mode. The identification of
C-N vibrations is a very difficult task since mixing of se-
veral bands is possible in the region assigned for the C-N
stretching vibrations which is in the regions 1,347.95 to
1,285.41 cm−1. In the present work, a weak band at
1,402.71 cm−1 and a strong band at 1,453.97 cm−1 were
seen in the FT-IR. It is observed that the ultrasonic wave
has no effect on nanoscale materials and the structure
does not change.
X-ray diffraction (XRD) technique was used to deter-
mine the ingredients of the sample. Figure 4 shows the
XRD patterns of typical sample 4 prepared by the
sonochemical process. The mean size of carvedilol
nanoparticles was calculated to be about 96 nm using
Scherrer's equation: D = Kλ/(β cos θ), where D is the
mean crystalline size (nm), λ is the wavelength of Cu Kαedilol (sample 4).
Figure 4 X-ray diffraction spectrum of nanocarvedilol in (A) sample 4.
Figure 5 DSC spectra of (A) carvedilol and (B) carvedilol nanoparticles.




Figure 6 Schematic of the experimental setup used for the
sonochemical reactions. (a) Carvedilol and carbon tetrachloride,
(b) sonochemical probe.
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in radian, and θ is the Bragg angle (°) [21].
The differential scanning calorimetry (DSC) curve of car-
vedilol showed a sharp endothermic peak (Tpeak = 115°C)
corresponding to its melting point, indicating its crystalline
nature (Figure 5A). In DSC studies, the characteristic en-
dothermic peaks, corresponding to drugs melting point,
were shifted toward higher temperature. This could be at-
tributed to the bigger particle sizes and uniform distribu-
tion of drugs (Figure 5B). Now, it is found that the melting
temperature of carvedilol nanoparticles decreases with
decreasing their particle size. The melting temperature
increases as its size increases. In other words, their mel-
ting temperature is lower than the corresponding bulk
materials.
It is also noteworthy that one of the problems of car-
vedilol is its very low aqueous solubility. The importance
of solubility enhancement is for the absorption of drug
from the site of absorption. The size of the solid particle
influences the solubility because as a particle becomes
smaller, the surface area-to-volume ratio of the particle
increases. The larger surface area allows a greater inter-
action with the solvent. Increase aqueous solubility with
the nanoparticle size increases the efficiency and/or re-
duces the side effects for certain drugs.
Conclusions
The described method for preparing carvedilol nano-
particles can potentially be used at industrial scale be-
cause it does not need special conditions, such as high
temperature, long times, or high-temperature and high-
pressure controlling. The advantage of using ultrasound
radiation is that it yields smaller particles. The same re-
sults have been shown for recent reports too. This ap-
proach can be used to improve the therapeutic efficacy
of poorly soluble drugs.
Methods
Material and methods
Carvedilol was purchased from Alborz Darou Pharma-
ceutical Company in Tehran, Iran. A multiwave ultrasonic
generator (Sonicator_3000, Misonix, Inc., Farmingdale,
NY, USA), equipped with a converter/transducer and ti-
tanium oscillator (horn), 12.5 mm in diameter, operating
at 20 kHz with a maximum power output of 600 W, was
employed. The morphology of synthesized samples was
studied using scanning electron microscopes (KYKY-
EM3200, KYKY Technology Development Ltd., Beijing,
China; Philips XL 30 and S-4160, Philips, Amsterdam,
The Netherlands) and by a sputtering technique with gold
as covering contrast material. The thermal analysis was
carried out on DSC Q10 V9.4 Build 287 (TA Instruments,New Castle, DE, USA). The XRD measurements of syn-
thesized samples were carried out using a Philips X-
pert PRO powder diffractometer (Philips, Amsterdam,
The Netherlands) with Cu Kα radiation (λ = 1.54 Å) in
the scan range of 0° to 100°. The IR spectra were
recorded using a Bruker spectrometer (Bruker AXS,
Inc., Madison, WI, USA) with KBr pellets in the range
of 400 to 4,000 cm−1.Synthesis of nanoparticles
Carvedilol and carbon tetrachloride were mixed to prepare
nanoparticles by ultrasonic method. The sonochemical re-
actions were carried in the sonochemical probe, as shown
in Figure 6. The ultrasonic device power and sonication
time were the parameters which were changed to reach
the optimum condition.
Then, the suspension was ultrasonically irradiated with a
high-density ultrasonic probe immersed directly into the
solution under various conditions (Table 1). The precipitate
was separated from the mother liquor by a centrifuge at
4,000 rpm for 3 min. The final product was dried at 50°C
in a vacuum system.
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